Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 17, 2018
Pharmacy Choice - News - Front Page Healthcare News - July 17, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/10/18 - Advisory - Several drugs containing valsartan being recalled due to contamination with a potential carcinogen
The valsartan was supplied by Zhejiang Huahai Pharmaceuticals. Keep taking your medicine if it contains valsartan, unless you have been told to stop by your doctor or pharmacist. If you are taking any medication containing valsartan, speak to your pharmacist who can tell you if your medicine is being recalled. If you have been using an affected pro
7/10/18 - Clinical Trial Finds Kerecis Omega3 Fish Skin Heals Wounds Significantly Faster than EpiFix
A double-blind, prospective, randomized clinical study found that wounds treated with Kerecis Omega3 Wound healed significantly faster than wounds treated with EpiFix from MiMedx . The Kerecis product is made from intact fish skin; EpiFix is made from human amnion membrane. Kerecis will unveil detailed results of the study at the annual s
7/10/18 - CORRECTION: House Republicans back LePage veto, keeping Medicaid expansion in limbo [Bangor Daily News, Maine]
July 09 AUGUSTA, Maine Republicans in the Maine House of Representatives on Monday upheld Gov. The bill vetoed this year by LePage would have put up to $54.7 million toward funding startup costs for expansion, with $31.2 million coming from the state budget and a possible $23.5 million from the Fund for a Healthy Maine, which is largely funded
7/10/18 - Global Electronic Health Records (EHR) Software Market Growth Analysis 2018 - Greenway, HealthFusion, IPatientCare, Kareo
The latest report on the global Electronic Health Records Software market presents answers to crucial questions that are important to comprehend developments in the said A holistic and detailed overview of the global Electronic Health Records Software market that includes information derived from utilizing various quantitative and qualitative...
7/10/18 - HHS Secretary Azar Issues Remarks at Coalition Summer Meeting
The U.S. Department of Health and Human Services issued the following remarks by Secretary Alex M. Azar II at the 340 B Coalition summer meeting:. "Thank you for that introduction, Maureen, and thank you to all of the members of the 340 B Coalition for welcoming me here today. "All of you are here because you share an interest in a program that h
7/10/18 - INDIAN DRUG-MAKERS HIT BY PRICE EROSION IN US MARKET
The prices of drugs in the US market, a major export destination for Indian companies, are eroding and so have affected manufacturers here. According to the data available with the industry, price erosion in Jan- Mar 2018 was around 8-10 percent and this is trend will continue in 2018-2019 also. The overall sales in the US dropped, for Sun Pharmace
7/10/18 - Market Survey: Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Forecast 2018-2025
Albany, NY 07/09/2018 This report studies the global Pacemakers and Cardiac Resynchronization Therapy Devices market status and forecast, categorizes the global Pacemakers and Cardiac Resynchronization Therapy Devices market size by key players, type, application, and region. This report focuses on the top players in North America, Europe, Ch
7/10/18 - Rep. Pallone Requests Hearing on REMS Abuse
"I would urge you to a hold a hearing soon on the anti-competitive practices of pharmaceutical companies and the abuses of FDA' s regulatory programs to delay generic competition," Pallone wrote to Walden and Burgess. Food and Drug Administration Commissioner Scott Gottlieb has been outspoken about pharmaceutical manufacturers' "gaming" of regulato
7/10/18 - US FDA Approves Adagene IO program IND for Solid Tumor and Non-Hodgkin Lympoma Ph1 trial
Adagene, Inc., an innovative antibody engineering and discovery company, has received notification from the FDA to proceed on its Investigational New Drug application to study its lead product in patients with advanced solid tumors and non-Hodgkin lymphoma. Adagene will investigate the safety and efficacy of ADG-106 therapy as a single agent acro
7/10/18 - Zika Virus Vaccines Market: Global Snapshot by 2022
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Zika Virus Vaccines in these regions, from 2012 to 2023, covering North America Europe Asia-Pacific South America Middle East and Africa. Global Zika Virus Vaccines market competition by top manufacturers, with p
7/9/18 - "Non-Beam Pumping Unit Driven by a Biaxial Motor" in Patent Application Approval Process (USPTO 20180163715)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor Su, Zhishen, filed on July 24, 2017, was made available online on June 21, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Purdue Pharma L.P.. The following quote w
7/9/18 - "Nutritional Formulations Including Human Milk Oligosaccharides and Antioxidants and Uses Thereof" in Patent Application Approval Process (USPTO...
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors BUCK, RACHAEL; DUSKA-MCEWEN, GERALYN O.; SCHALLER, JOSEPH P., filed on February 9, 2018, was made available online on June 21, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is
7/9/18 - "Ph-Weighted Mri Using Fast Amine Chemical Exchange Saturation Transfer (Cest) Imaging" in Patent Application Approval Process (USPTO 20180164393)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Ellingson, Benjamin; Harris, Robert, filed on May 27, 2016, was made available online on June 21, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a compa
7/9/18 - "Pharmaceutical Composition for Treatment of Depression and Preparation Method Thereof" in Patent Application Approval Process (USPTO 20180161386)
By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventors YU, Luping; WANG, Wencheng, filed on June 3, 2016, was made available online on June 21, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or ins
7/9/18 - "Substituted Aromatic Compounds and Pharmaceutical Uses Thereof" in Patent Application Approval Process (USPTO 20180162799)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors ZACHARIE, Boulos; PENNEY, Christopher; GAGNON, Lyne; BIENVENU, Jean- Francois; PERRON, Valerie; GROUIX, Brigitte, filed on February 7, 2018, was made available online on June 21, 2018, according to news reporting originating from Washington, D.C., b
7/9/18 - "Treating Patients with TTFields with the Electrode Positions Optimized Using Deformable Templates" in Patent Application Approval Process (USPTO...
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors URMAN, Noa; BOMZON, Zeev, filed on December 13, 2017, was made available online on June 21, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Novocure Limited. See,
7/9/18 - 100th Surgical Implantation of ZIP ULTRA? MIS Interspinous Device Performed in Canada
Aurora Spine Corporation announced today the 100 th surgical implantation of the company's ZIP ULTRA minimally invasive interspinous device in Canada. These surgeries are part of Aurora Spine's continuing efforts to expand the use of the Company s ZIP MIS Fusion System in North America.. "We are very excited to continue offering our ZIP
7/9/18 - 5 Top Weekly NASDAQ Biotech Stocks: Adamis Rises 45.31 Percent
Aside from the companies highlighted on our weekly top NASDAQ biotech stocks list, Elite Pharmaceuticals received US Food and Drug Administration approval for generic percocet tablets, while Sorrento Therapeutics acquired the Sofusa lymphatic delivery technology platform from Kimberly-Clark. Later in the week Bristol-Myers Squibb received...
7/9/18 - Acacia Pharma Provides Operating Update for the First Half 2018
Cambridge, UK and Indianapolis, US- 9 July 2018: Acacia Pharma Group plc, provides an unaudited operating update for the first half 2018. Dr Julian Gilbert, CEO of Acacia Pharma, commented: "The Group has made important progress during the first half 2018 preparing for the launch, if approved, of BARHEMSYS (TM) for the treatment and prevention of p
7/9/18 - Actinium to Host Webcast on July 10, 2018 to Discuss Actimab-A MRD clinical trial for Minimal Residual Disease in Postremission AML Patients
Actinium Pharmaceuticals, Inc., provided a reminder that it will host a webcast on July 10, 2018 at 8:00 AM ET. Joseph Jurcic, Director of Hematologic Malignancies; Professor of Medicine at Columbia University Medical Center and Dr. Mark Berger, Chief Medical Officer and Sandesh Seth, Chairman and CEO of Actinium Pharmaceuticals, Inc. will lead t
7/9/18 - Advicenne confirms ADV7103 'safety and efficacy after 24 months in the Phase III Extension Study
Advicenne, a specialist pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases, announces preliminary results of the Phase III Extension Study with ADV7103 in Distal Renal Tubular Acidosis. Dr Luc Andre Granier, co-founder and CEO of Advicenne, says:' We are..
7/9/18 - Aeromics Initiates Phase 1 Clinical Trial of CNS Edema Inhibitor AER-271 In Healthy Human Volunteers
Aeromics, Inc., a privately-held, clinical-stage pharmaceutical company focused on controlling cerebral edema for people affected by disabling and life-threatening severe ischemic stroke, announced today the initiation of a Phase 1 clinical trial in healthy volunteers of its first-in-class drug candidate, AER-271.. The clinical study will include
7/9/18 - AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial
By a News Reporter-Staff News Editor at Pharma Business Week AIVITA Biomedical, a biotech company specializing in innovative stem cell applications, announced the U.S. Food and Drug Administration has cleared its Investigational New Drug application for a Phase II clinical trial investigating the Company's ROOT OF CANCER technology in patients wi
7/9/18 - Alcohol Addiction Rehab Los Angeles Offers The Best Drug Outpatient Treatment Services
Detox Centers Los Angeles provides effective drug outpatient treatment programs that produce great results. Addiction is a chronic disease that affects the lives of millions of people. If you are struggling with drugs, Los Angeles drug outpatient treatment could be your path back to health.
7/9/18 - Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria PNH in...
Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria PNH in the U.S.. By a News Reporter-Staff News Editor at Pharma Business Week Alexion Pharmaceuticals, Inc. announced the submission of a Biologics License Application to the U.S. Food and Drug Administrati
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415